For a 57‑year‑old man with type 2 diabetes (A1c 10.1 %), active large B‑cell lymphoma and septic shock from a urinary‑tract infection, currently on glargine (Lantus) 10 U daily and an IV insulin infusion averaging 0.5 U/h, with post‑meal glucose ≈ 281 mg/dL after lunch and ≈ 514 mg/dL after dinner, what should his glargine dose, carbohydrate‑to‑insulin ratio, and correction factor be to achieve an intensive care unit target glucose of 140‑180 mg/dL and transition to a basal‑bolus subcutaneous regimen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Dosing Recommendations for Critically Ill Patient Transitioning from IV Insulin

For this 57-year-old man (approximately 70 kg) transitioning from IV insulin after septic shock, calculate his total 24-hour IV insulin dose (0.5 U/h × 24 = 12 units), then give 6 units of Lantus once daily in the evening and 2 units of rapid-acting insulin before each meal, with aggressive titration every 3 days until glucose stabilizes.

Immediate Transition Protocol

Calculate the Subcutaneous Insulin Dose

  • Total the IV insulin infused over the previous 24 hours when glucose has been stable: 0.5 units/hour × 24 hours = 12 units total daily dose 1, 2.

  • Give 50% as basal insulin (Lantus): 12 ÷ 2 = 6 units of Lantus once daily, administered in the evening 3, 1, 2.

  • Give the remaining 50% as prandial insulin: 12 ÷ 2 = 6 units total, divided by 3 meals = 2 units of rapid-acting insulin before each meal 3, 1, 2.

Critical Timing to Prevent Rebound Hyperglycemia

  • Administer the first Lantus dose exactly 2–4 hours before discontinuing the IV insulin infusion to allow adequate subcutaneous absorption and prevent dangerous rebound hyperglycemia 1, 2.

  • The IV insulin must overlap with subcutaneous administration; never stop IV insulin abruptly without prior subcutaneous dosing 1, 2.

Aggressive Titration for Severe Hyperglycemia

Basal Insulin (Lantus) Titration

Given the severe hyperglycemia (A1c 10.1%, post-meal glucose 281–514 mg/dL), this patient requires aggressive dose escalation:

  • Increase Lantus by 4 units every 3 days if fasting glucose remains ≥180 mg/dL 4, 2.

  • Increase by 2 units every 3 days if fasting glucose is 140–179 mg/dL 4, 2.

  • Target fasting glucose: 80–130 mg/dL (in the ICU, a slightly higher target of 140–180 mg/dL is acceptable initially) 4, 2.

  • For this patient, expect to reach 15–20 units of Lantus within 1–2 weeks given the A1c of 10.1% and current hyperglycemia 4.

Prandial Insulin Titration

  • Increase each meal's rapid-acting insulin by 1–2 units every 3 days based on 2-hour postprandial glucose readings 4, 2.

  • Target postprandial glucose <180 mg/dL 4, 2.

  • Given the post-lunch glucose of 281 mg/dL and post-dinner glucose of 514 mg/dL, expect to escalate to 4–6 units per meal within 1–2 weeks 4.

Carbohydrate-to-Insulin Ratio and Correction Factor

Initial Carbohydrate Ratio

  • Start with 1 unit of rapid-acting insulin per 15 grams of carbohydrate as a standard initial ratio 4.

  • Once the total daily dose (TDD) stabilizes, calculate a more precise ratio using 450 ÷ TDD for rapid-acting insulin 4.

  • Example: If TDD reaches 30 units, the ratio becomes 450 ÷ 30 = 1 unit per 15 grams of carbohydrate 4.

Correction Factor (Insulin Sensitivity Factor)

  • Calculate using 1500 ÷ TDD for regular insulin or 1700 ÷ TDD for rapid-acting analogs 4.

  • Example: With a TDD of 30 units, the correction factor is 1700 ÷ 30 = 1 unit lowers glucose by approximately 57 mg/dL 4.

  • Simplified correction scale for immediate use: Give 2 units of rapid-acting insulin for pre-meal glucose >250 mg/dL and 4 units for glucose >350 mg/dL 4, 2.

Special Considerations for This Patient

Septic Shock and Acute Illness

  • Insulin requirements are dramatically increased during acute illness and sepsis, often requiring 2–3 times the usual dose 4.

  • As the patient recovers from septic shock, insulin requirements will decrease; monitor closely for hypoglycemia and reduce doses by 10–20% if glucose falls below 70 mg/dL 4, 2.

Renal Function Monitoring

  • UTI and septic shock may have compromised renal function; if eGFR <45 mL/min, use more conservative dosing (reduce calculated doses by 20–30%) and monitor more frequently for hypoglycemia 4.

Nutritional Status

  • If the patient has poor oral intake or is NPO, reduce the prandial insulin and rely primarily on basal insulin plus correction doses every 4–6 hours 4, 2.

  • Once eating regularly, advance to the full basal-bolus regimen as outlined above 4, 2.

Intensive Monitoring Requirements

  • Check capillary blood glucose before each meal and at bedtime during the first 24–48 hours after transition 2.

  • Check glucose every 2–4 hours initially if the patient is not eating regular meals 1, 2.

  • Monitor serum potassium closely as insulin drives potassium intracellularly, especially important in the setting of sepsis and UTI 1.

Critical Threshold: When to Add More Prandial Coverage

  • When Lantus exceeds 0.5 units/kg/day (approximately 35 units for a 70 kg patient) without achieving glucose targets, prioritize intensifying prandial insulin rather than continuing to escalate basal insulin alone 4.

  • Clinical signs of "overbasalization" include bedtime-to-morning glucose differential ≥50 mg/dL, hypoglycemia, and high glucose variability 4.

Common Pitfalls to Avoid

  • Never use sliding-scale insulin as monotherapy; this patient requires scheduled basal-bolus therapy, not reactive correction doses alone 4, 2.

  • Never give rapid-acting insulin at bedtime as a sole correction dose, as this markedly raises nocturnal hypoglycemia risk 4, 2.

  • Never stop IV insulin before administering subcutaneous basal insulin; the 2–4 hour overlap is mandatory to prevent rebound hyperglycemia 1, 2.

  • Do not delay aggressive titration in a patient with A1c 10.1% and glucose readings of 281–514 mg/dL; this degree of hyperglycemia requires rapid dose escalation every 3 days 4.

References

Guideline

Transitioning from IV to Subcutaneous Insulin in HHS

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Calculating Long-Acting Insulin Requirements in ICU Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Initial Dosing for Lantus (Insulin Glargine) in Patients Requiring Insulin Therapy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.